Ben Z. Stanger, MD, PhD
Metastasis, tumor immunology, metabolism and therapy resistance in pancreatic cancer
Dr. Stanger’s laboratory investigates multiple aspects of pancreatic cancer biology — metastasis, tumor immunology, metabolism and therapy resistance. His research integrates mouse models with human data to identify new vulnerabilities that can then be assessed clinically.
After an S.B. from MIT and a combined MD and PhD from Harvard Medical School, Dr. Stanger completed a residency in internal medicine at UC San Francisco, a clinical fellowship in gastroenterology at Massachusetts General Hospital, and a research fellowship in molecular biology at Harvard. In 2006 he joined the Penn faculty in the Gastroenterology Division and the Abramson Family Cancer Research Institute. He is now Hanna Wise Professor in Cancer Research at the University of Pennsylvania and Director of the Penn Pancreatic Cancer Research Center.
Seed grants start at $50,000 — awarded by scientists, reported on annually.
Donate →Ben Z. Stanger, MD, PhD
Metastasis, tumor immunology, metabolism and therapy resistance in pancreatic cancer
Dr. Stanger’s laboratory investigates multiple aspects of pancreatic cancer biology — metastasis, tumor immunology, metabolism and therapy resistance. His research integrates mouse models with human data to identify new vulnerabilities that can then be assessed clinically.
After an S.B. from MIT and a combined MD and PhD from Harvard Medical School, Dr. Stanger completed a residency in internal medicine at UC San Francisco, a clinical fellowship in gastroenterology at Massachusetts General Hospital, and a research fellowship in molecular biology at Harvard. In 2006 he joined the Penn faculty in the Gastroenterology Division and the Abramson Family Cancer Research Institute. He is now Hanna Wise Professor in Cancer Research at the University of Pennsylvania and Director of the Penn Pancreatic Cancer Research Center.
Seed grants start at $50,000 — awarded by scientists, reported on annually.
Donate →